Enter your login e-mail to the account
Search
- Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - The diagnosis and treatment of multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(4/2015, Interdisciplinary consilium )
- Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(1/2015, Psychopharmacology )
- Hair loss due to treatment of multiple sclerosis
MUDr. Radek Litvik, MUDr. Olga Zapletalová
(2/2017, From the boundary of neurology ) - Smoking and multiple sclerosis
Doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(2/2017, Review articles ) - Woman and multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(6/2014, Main topic ) - Sympózium praktickej neurológie Neurológia pre prax, Tatranská Lomnica, VIII. ročník
doc. MUDr. Vladimír Donáth, PhD.
(6/2014, Events ) - Escalation therapy in multiple sclerosis
MUDr. Pavel Ryška, Ph.D., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2016, Case reports ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - New ways of administering injection drugs in relapsing multiple sclerosis
MUDr. Jiří Piťha
(5/2015, Review articles )
- Long-term risk of tattoo in children
doc. MUDr. Tibor Danilla, CSc., MUDr. Michaela Petrovajová, MUDr. Alena Točíková, PhD.
(6/2011, Review articles )
- Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus )
- Long-term risk of tattoo in children
MUDr. Michaela Petrovajová, MUDr. Alena Točíková, PhD., doc. MUDr. Tibor Danilla, CSc.
(2/2011, Original articles & case reports )
- FARMAKOLOGICKÁ LÉČBA HYPERAKTIVNÍHO MOČOVÉHO MĚCHÝŘE
MUDr. Michael Pešl, FEBU
(1/2007, clearly )
- Principles of pharmacological pregnancy termination and uterine evacuation
prof. MUDr. Pavel Trávník, DrSc.
(2/2015, Current pharmacotherapy ) - Overview of H1 antihistamines intended not only for seasonal pollen allergy
prof. PharmDr. Martin Doležal, Ph.D.
(2/2013, Current pharmacotherapy )